News
Novo Nordisk teams with telehealth firms Hims, Ro to sell Wegovy at lower price
Novo Nordisk A/S said it would sell its popular weight-loss drug Wegovy for a steeply reduced price on several telehealth platforms. The strategy comes as rival Eli Lilly & Co. is working with telehealth firms to distribute lower-cost vials of its own obesity medication,
Telehealth company LifeMD bought assets from Optimal Human Health MD to accelerate its push into the women’s health market. | ...
Click in for more news from The Hill{beacon} Health Care Health Care The Big Story Novo Nordisk partners with telehealth ...
Novo is expanding its direct-to-consumer efforts around its obesity drug Wegovy, partnering with telehealth companies ...
Novo Nordisk appears to be letting compounded GLP-1 bygones be bygones—at least, in one respect. | Novo Nordisk appears to be ...
Shares of Novo Nordisk ( NVO 3.94%) are up on Tuesday. The company's stock gained 3.9% as of 2:40 p.m. ET today and was up as ...
Good morning. Amazon denies a reported tariff label plan after the White House blasted it as “hostile.” Novo Nordisk is ...
Eli Lilly Wednesday filed lawsuits against four telehealth companies alleging they are deceiving consumers by selling ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback